These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 34896445)

  • 1. Intravenous pegylated liposomal prednisolone outperforms intramuscular methylprednisolone in treating rheumatoid arthritis flares: A randomized controlled clinical trial.
    Metselaar JM; Middelink LM; Wortel CH; Bos R; van Laar JM; Vonkeman HE; Westhovens R; Lammers T; Yao SL; Kothekar M; Raut A; Bijlsma JWJ
    J Control Release; 2022 Jan; 341():548-554. PubMed ID: 34896445
    [TBL] [Abstract][Full Text] [Related]  

  • 2. PET Imaging of Liposomal Glucocorticoids using
    Gawne PJ; Clarke F; Turjeman K; Cope AP; Long NJ; Barenholz Y; Terry SYA; de Rosales RTM
    Theranostics; 2020; 10(9):3867-3879. PubMed ID: 32226525
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The efficacy and safety of rituximab in patients with active rheumatoid arthritis despite methotrexate treatment: results of a phase IIB randomized, double-blind, placebo-controlled, dose-ranging trial.
    Emery P; Fleischmann R; Filipowicz-Sosnowska A; Schechtman J; Szczepanski L; Kavanaugh A; Racewicz AJ; van Vollenhoven RF; Li NF; Agarwal S; Hessey EW; Shaw TM;
    Arthritis Rheum; 2006 May; 54(5):1390-400. PubMed ID: 16649186
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Analysis of efficacy and safety of multiple intravenous infusion of anti-tumor necrosis factor-alpha monoclonal antibody (Remicade) combined with methotrexate compared with sodium aurothiomalate and intramuscular depot methylprednisolone in rheumatoid arthritis].
    Wiland P; Głowska A; Chlebicki A; Szechiński J
    Pol Arch Med Wewn; 2002 Nov; 108(5):1055-63. PubMed ID: 12685246
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A phase III, randomized, two-armed, double-blind, parallel, active controlled, and non-inferiority clinical trial to compare efficacy and safety of biosimilar adalimumab (CinnoRA®) to the reference product (Humira®) in patients with active rheumatoid arthritis.
    Jamshidi A; Gharibdoost F; Vojdanian M; Soroosh SG; Soroush M; Ahmadzadeh A; Nazarinia MA; Mousavi M; Karimzadeh H; Shakibi MR; Rezaieyazdi Z; Sahebari M; Hajiabbasi A; Ebrahimi AA; Mahjourian N; Rashti AM
    Arthritis Res Ther; 2017 Jul; 19(1):168. PubMed ID: 28728599
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Two Types of Liposomal Formulations Improve the Therapeutic Ratio of Prednisolone Phosphate in a Zebrafish Model for Inflammation.
    Xie Y; Papadopoulou P; de Wit B; d'Engelbronner JC; van Hage P; Kros A; Schaaf MJM
    Cells; 2022 Feb; 11(4):. PubMed ID: 35203318
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Double blind placebo controlled trial of pulse treatment with methylprednisolone combined with disease modifying drugs in rheumatoid arthritis.
    Hansen TM; Kryger P; Elling H; Haar D; Kreutzfeldt M; Ingeman-Nielsen MW; Olsson AT; Pedersen C; Rahbek A; Tvede N
    BMJ; 1990 Aug; 301(6746):268-70. PubMed ID: 2202458
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A randomized, controlled study of a single intra-articular injection of etanercept or glucocorticosteroids in patients with rheumatoid arthritis.
    Bliddal H; Terslev L; Qvistgaard E; Konig M; Holm CC; Rogind H; Boesen M; Danneskiold-Samsøe B; Torp-Pedersen S
    Scand J Rheumatol; 2006; 35(5):341-5. PubMed ID: 17062431
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A pilot study on the use of prednisolone-encapsulated liposomes for the treatment of moderate-to-severe Graves' orbitopathy with reduced systemic steroid exposure.
    Detiger SE; Kremer TM; A S H Dalm V; de Keizer ROB; Wubbels RJ; Metselaar JM; van Hagen PM; Peeters RP; Paridaens D
    Acta Ophthalmol; 2021 Nov; 99(7):797-804. PubMed ID: 33423386
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Switching to Biosimilar SDZ-ADL in Patients with Moderate-to-Severe Active Rheumatoid Arthritis: 48-Week Efficacy, Safety and Immunogenicity Results From the Phase III, Randomized, Double-Blind ADMYRA Study.
    Wiland P; Jeka S; Dokoupilová E; Brandt-Jürgens J; Miranda Limón JM; Cantalejo Moreira M; Cabello RV; Jauch-Lembach J; Thakur A; Haliduola H; Brueckmann I; Gaylis NB
    BioDrugs; 2020 Dec; 34(6):809-823. PubMed ID: 33119861
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A randomized double-blind controlled trial of sulphasalazine combined with pulses of methylprednisolone or placebo in the treatment of rheumatoid arthritis.
    Ciconelli RM; Ferraz MB; Visioni RA; Oliveira LM; Atra E
    Br J Rheumatol; 1996 Feb; 35(2):150-4. PubMed ID: 8612028
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Enhanced brain delivery of liposomal methylprednisolone improved therapeutic efficacy in a model of neuroinflammation.
    Gaillard PJ; Appeldoorn CC; Rip J; Dorland R; van der Pol SM; Kooij G; de Vries HE; Reijerkerk A
    J Control Release; 2012 Dec; 164(3):364-9. PubMed ID: 22732475
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dose escalation of parenteral methotrexate in active rheumatoid arthritis that has been unresponsive to conventional doses of methotrexate: a randomized, controlled trial.
    Lambert CM; Sandhu S; Lochhead A; Hurst NP; McRorie E; Dhillon V
    Arthritis Rheum; 2004 Feb; 50(2):364-71. PubMed ID: 14872477
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Safety of intrathecal route: focus to methylprednisolone acetate (Depo-Medrol) use.
    Schlatter J; Nguyen D; Zamy M; Kabiche S; Fontan JE; Cisternino S
    Eur Spine J; 2019 Jan; 28(1):21-30. PubMed ID: 29151132
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-circulating liposomes for i.v. targeted delivery of glucocorticoids in arthritis.
    Metselaar JM; Wauben MH; Boerman OC; Van Lent PL; Storm G
    Cell Mol Biol Lett; 2002; 7(2):291-2. PubMed ID: 12097962
    [No Abstract]   [Full Text] [Related]  

  • 16. A comparative clinical study of PF-06410293, a candidate adalimumab biosimilar, and adalimumab reference product (Humira®) in the treatment of active rheumatoid arthritis.
    Fleischmann RM; Alten R; Pileckyte M; Lobello K; Hua SY; Cronenberger C; Alvarez D; Bock AE; Sewell KL
    Arthritis Res Ther; 2018 Aug; 20(1):178. PubMed ID: 30111357
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Liposomal amphotericin B: a review of its use as empirical therapy in febrile neutropenia and in the treatment of invasive fungal infections.
    Moen MD; Lyseng-Williamson KA; Scott LJ
    Drugs; 2009; 69(3):361-92. PubMed ID: 19275278
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [(18)]F FDG PET/CT imaging to monitor the therapeutic effect of liposome-encapsulated prednisolone in experimental rheumatoid arthritis.
    van der Geest T; Metselaar JM; Gerrits D; van Lent PL; Storm G; Laverman P; Boerman OC
    J Control Release; 2015 Jul; 209():20-6. PubMed ID: 25902038
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy and safety of sirukumab in patients with active rheumatoid arthritis refractory to anti-TNF therapy (SIRROUND-T): a randomised, double-blind, placebo-controlled, parallel-group, multinational, phase 3 study.
    Aletaha D; Bingham CO; Tanaka Y; Agarwal P; Kurrasch R; Tak PP; Popik S
    Lancet; 2017 Mar; 389(10075):1206-1217. PubMed ID: 28215362
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Contact allergy to miripirium chloride in Depo-Medrol.
    Färm G; Erikssohn I
    Contact Dermatitis; 2001 Feb; 44(2):127. PubMed ID: 11205399
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.